click below
click below
Normal Size Small Size show me how
135 Stack 2
EtOH, intro to neurodegen, PD
| Question | Answer |
|---|---|
| Acetaldehyde syndrome Inhibitors of Acetaldehyde DeHase | * Metronidazole * Cephalosporins with NMTT (cefaperazone, cefamandol) * tolbutamide * chlorpropamide |
| Disulfuram (ANTABUSE) | * inhibits acetaldehyde DeHase * EtOh Adversion Technique * EtOH received during this treatment leads to acetaldehyde syndrome * Subject can't intake EtOH 3 - 14 days after disulfuram admin |
| Drugs to reduce craving & autonomic manifestations of dependence | 1. clonide 2. naltrexone 3. acamprosate (NMDA Antagonist) [BDZ (affect Cl ch) + NMDA Antagonist)] --> Good to titrate pt from sed hypnotic (EtOH) |
| Fomepizole | ANTIZOLE * inhibits the conversion of Alcohols to Aldehydes (inc excretion of parent cmpd) |
| Donepezil | Aricept * Cholinesterase Inhibitors (inc ACH activity; Alzheimer's) |
| Rivastigmine | Exelon * Cholinesterase Inhibitors (inc ACH activity; Alzheimer's) |
| Galantamine | Razadyne * Cholinesterase Inhibitors (inc ACH activity; Alzheimer's) |
| Tacrine | Cognex * Cholinesterase Inhibitors (inc ACH activity; Alzheimer's) |
| Nemantine | NAMEDNA * NMDA R Antagonist |
| Riluzole | RILUTEK * inhibits Glutaminergic neuronal activity & release; inh voltage-gated Na+ Chs * Amylotrophic Lateral Sclerosis. * reduces spasticity, but not dz; * Hepatotoxic |
| Glucocorticoids | MS tx anti-inflammatory |
| Interferon beta1a | AVONEX * reduce T lymphocyte activity against myelin |
| Glatiramer acetate | COPAXONE * 4 aa peptide that induces T cells to secrete cytokines to reduce lesion pdtn |
| LDOPA/carbidopa | SINEMET * LDOPA gets into CNS via aa TRA * carbidopa inhibits peripheral decarboxylation |
| SINEMET Warnings/Precautions | Abrupt withdrawal causes Neuroleptic Malignant Syndrome: inc body temp, muscle rigidity, and tachycardia/sweating; malignant melanoma, or lower seizure threshold. |
| SINEMET DDIs (4): | 1. Antipsychotic agents 2. Anticholinergic agents 3. Nonselective MAOIs 4. Methyldopa |
| Amantadine | SYMMETREL * Modifies DA TRA * inc DA release & inhs reuptake * AE: levido reticularis: blotches on skin due to excessive skin vasodilation. |
| SYMMETREL DDIs (2) | 1. Anticholinergic drugs 2. CNS Stimulants |
| Entacapone | COMTAN * Inhibits COMT * Used w SINEMET (STALEVO?) * Elim via biliary excretion |
| COMTAN DDIs (2): | 1. Nonselective MAOIs 2. Drugs metabolized by COMT: bitolerol, dobutamine, DA, E, isoproterenol, methyldopa, NE |
| Tolcapone | TASMAR * older COMT Inhibitor * RENAL EXCRETION! *FUlminant Liver Failure * Interferes with Warfarin/INR |
| Selegiline Hydrochloride | ELDEPRYL * MAOB Inh * inc AE of LDOPA |
| Rasagiline | AZILECT * MAOb Inhib |
| ELDEPRYL DDIs (4): | 1. Tyramine rxns 2. Meperidine 3. SSRIs 4. Catecholamines |
| Bromocriptine | PARLODEL * ERgot alkaloid * DA agonist |
| Pergolide | PERMAX * ergot alkaloid * DA agonist |
| Pramipexole | MIRAPEX * nonergot alkaloids * suddenly fall asleep * elimin (renal exc) is dec with cimetidine, ranitidne, verapamil, quinidine |
| Ropinirole | REQUIP * oonergot alkaloid DA agonist * metab by CYP1A2, inhb by CIPRO * effect reduced by antipsychotics |
| Benztropiine | COGENTIN * PD Anticholinergic Drugs |
| Trihexyphenidyl | ARTANE * PD Anticholinergic Drugs |
| Diphenhydramine | BENADRYL * PD Anticholinergic Drugs |